Does Androgen Deprivation Therapeutic Drugs Interact with Infliximab Dyyb?
Androgen Deprivation Therapeutic Drugs and Infliximab Dyyb have a major drug interaction according to U.S. FDA drug labeling data. Therapeutic infectious agents not recommended concurrently with infliximab due to increased infection risk. The mechanism involves immunosuppression from tnf antagonism. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Major
- Infliximab Dyyb Class
- Tumor Necrosis Factor Blocker
- Management
- Close medical supervision required
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Androgen Deprivation Therapeutic Drugs and Infliximab Dyyb occurs because immunosuppression from tnf antagonism. Clinically, this means therapeutic infectious agents not recommended concurrently with infliximab due to increased infection risk. This is classified as a major interaction, meaning it could cause serious harm if not properly managed. Your healthcare provider may need to adjust dosages, substitute one medication, or increase monitoring frequency.
What To Tell Your Doctor or Pharmacist
If you are taking Androgen Deprivation Therapeutic Drugs and your doctor is considering prescribing Infliximab Dyyb (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask how frequently you should be monitored while these are co-prescribed
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider